カテゴリー： LP Information, 世界, 医療/バイオ

人工血管細胞のグローバル市場予測2023-2029

◆英語タイトル：Global Artificial Blood Cells Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23MY4091）◆商品コード：LP23MY4091
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年5月
◆ページ数：105
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LP Informationの最新刊調査レポート「人工血管細胞のグローバル市場」は、過去の販売実績から2022年の世界の人工血管細胞の総販売量を検討し、2023年から2029年の予測される人工血管細胞の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の人工血管細胞の市場規模を掲載し、XXX百万米ドル規模の世界の人工血管細胞市場の詳細な分析を提供します。本インサイトレポートは、世界の人工血管細胞業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の人工血管細胞市場における各社の独自のポジションをより深く理解するために、人工血管細胞製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の人工血管細胞市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。人工血管細胞の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。人工血管細胞の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。人工血管細胞のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

人工血管細胞の世界主要メーカーとしては、Dextro-Sang Corporation、 BioPure Corporation、 Sangart、 Northfield Laboratories、 Baxter International、 Dentritech、 FluorO2 Therapeutics、 Nuvox Pharma、 Alpha Therapeutic Corporation、 HemoBioTechなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の人工血管細胞市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場セグメンテーション】

この調査では人工血管細胞市場をセグメンテーションし、種類別 (動物ヘモグロビン、ヒトヘモグロビン、幹細胞、その他)、用途別 (心血管疾患、貧血、臓器移植、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：動物ヘモグロビン、ヒトヘモグロビン、幹細胞、その他

・用途別区分：心血管疾患、貧血、臓器移植、その他

・地域別区分
南北アメリカ（米国、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の人工血管細胞市場の10年間の市場状況・展望は？
・世界および地域別に見た人工血管細胞市場成長の要因は何か？
・人工血管細胞の市場機会はエンドマーケットの規模によってどのように変化するのか？
・人工血管細胞のタイプ別、用途別の内訳は？
・新型コロナウイルスとロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：人工血管細胞の年間販売量2018-2029、地域別現状・将来分析
・人工血管細胞の種類別セグメント：動物ヘモグロビン、ヒトヘモグロビン、幹細胞、その他
・人工血管細胞の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・人工血管細胞の用途別セグメント：心血管疾患、貧血、臓器移植、その他
・人工血管細胞の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の人工血管細胞市場
・企業別のグローバル人工血管細胞市場データ：2018-2023年の年間販売量、市場シェア
・企業別の人工血管細胞の年間売上：2018-2023年の売上、市場シェア
・企業別の人工血管細胞販売価格
・主要企業の人工血管細胞生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

人工血管細胞の地域別レビュー
・地域別の人工血管細胞市場規模2018-2023：年間販売量、売上
・主要国別の人工血管細胞市場規模2018-2023：年間販売量、売上
・南北アメリカの人工血管細胞販売の成長
・アジア太平洋の人工血管細胞販売の成長
・ヨーロッパの人工血管細胞販売の成長
・中東・アフリカの人工血管細胞販売の成長

南北アメリカ市場
・南北アメリカの国別の人工血管細胞販売量、売上（2018-2023）
・南北アメリカの人工血管細胞の種類別販売量
・南北アメリカの人工血管細胞の用途別販売量
・米国市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の人工血管細胞販売量、売上（2018-2023）
・アジア太平洋の人工血管細胞の種類別販売量
・アジア太平洋の人工血管細胞の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の人工血管細胞販売量、売上（2018-2023）
・ヨーロッパの人工血管細胞の種類別販売量
・ヨーロッパの人工血管細胞の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の人工血管細胞販売量、売上（2018-2023）
・中東・アフリカの人工血管細胞の種類別販売量
・中東・アフリカの人工血管細胞の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・人工血管細胞の製造コスト構造分析
・人工血管細胞の製造プロセス分析
・人工血管細胞の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・人工血管細胞の主要なグローバル販売業者
・人工血管細胞の主要なグローバル顧客

地域別の人工血管細胞市場予測レビュー
・地域別の人工血管細胞市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・人工血管細胞の種類別市場規模予測
・人工血管細胞の用途別市場規模予測

主要企業分析
Dextro-Sang Corporation、 BioPure Corporation、 Sangart、 Northfield Laboratories、 Baxter International、 Dentritech、 FluorO2 Therapeutics、 Nuvox Pharma、 Alpha Therapeutic Corporation、 HemoBioTech
・企業情報
・人工血管細胞製品
・人工血管細胞販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

LPI (LP Information)’ newest research report, the “Artificial Blood Cells Industry Forecast” looks at past sales and reviews total world Artificial Blood Cells sales in 2022, providing a comprehensive analysis by region and market sector of projected Artificial Blood Cells sales for 2023 through 2029. With Artificial Blood Cells sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Blood Cells industry.
This Insight Report provides a comprehensive analysis of the global Artificial Blood Cells landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Blood Cells portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Blood Cells market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Blood Cells and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Blood Cells.
The global Artificial Blood Cells market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Artificial Blood Cells is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Artificial Blood Cells is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Artificial Blood Cells is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Artificial Blood Cells players cover Dextro-Sang Corporation, BioPure Corporation, Sangart, Northfield Laboratories, Baxter International, Dentritech, FluorO2 Therapeutics, Nuvox Pharma and Alpha Therapeutic Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Blood Cells market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Animal Hemoglobin
Human Hemoglobin
Stem Cell
Others
Segmentation by application
Cardiovascular Diseases
Anemia
Organ Transplant
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Dextro-Sang Corporation
BioPure Corporation
Sangart
Northfield Laboratories
Baxter International
Dentritech
FluorO2 Therapeutics
Nuvox Pharma
Alpha Therapeutic Corporation
HemoBioTech
Key Questions Addressed in this Report
What is the 10-year outlook for the global Artificial Blood Cells market?
What factors are driving Artificial Blood Cells market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Artificial Blood Cells market opportunities vary by end market size?
How does Artificial Blood Cells break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artificial Blood Cells Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Artificial Blood Cells by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Artificial Blood Cells by Country/Region, 2018, 2022 & 2029
2.2 Artificial Blood Cells Segment by Type
2.2.1 Animal Hemoglobin
2.2.2 Human Hemoglobin
2.2.3 Stem Cell
2.2.4 Others
2.3 Artificial Blood Cells Sales by Type
2.3.1 Global Artificial Blood Cells Sales Market Share by Type (2018-2023)
2.3.2 Global Artificial Blood Cells Revenue and Market Share by Type (2018-2023)
2.3.3 Global Artificial Blood Cells Sale Price by Type (2018-2023)
2.4 Artificial Blood Cells Segment by Application
2.4.1 Cardiovascular Diseases
2.4.2 Anemia
2.4.3 Organ Transplant
2.4.4 Others
2.5 Artificial Blood Cells Sales by Application
2.5.1 Global Artificial Blood Cells Sale Market Share by Application (2018-2023)
2.5.2 Global Artificial Blood Cells Revenue and Market Share by Application (2018-2023)
2.5.3 Global Artificial Blood Cells Sale Price by Application (2018-2023)
3 Global Artificial Blood Cells by Company
3.1 Global Artificial Blood Cells Breakdown Data by Company
3.1.1 Global Artificial Blood Cells Annual Sales by Company (2018-2023)
3.1.2 Global Artificial Blood Cells Sales Market Share by Company (2018-2023)
3.2 Global Artificial Blood Cells Annual Revenue by Company (2018-2023)
3.2.1 Global Artificial Blood Cells Revenue by Company (2018-2023)
3.2.2 Global Artificial Blood Cells Revenue Market Share by Company (2018-2023)
3.3 Global Artificial Blood Cells Sale Price by Company
3.4 Key Manufacturers Artificial Blood Cells Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artificial Blood Cells Product Location Distribution
3.4.2 Players Artificial Blood Cells Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Artificial Blood Cells by Geographic Region
4.1 World Historic Artificial Blood Cells Market Size by Geographic Region (2018-2023)
4.1.1 Global Artificial Blood Cells Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Artificial Blood Cells Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Artificial Blood Cells Market Size by Country/Region (2018-2023)
4.2.1 Global Artificial Blood Cells Annual Sales by Country/Region (2018-2023)
4.2.2 Global Artificial Blood Cells Annual Revenue by Country/Region (2018-2023)
4.3 Americas Artificial Blood Cells Sales Growth
4.4 APAC Artificial Blood Cells Sales Growth
4.5 Europe Artificial Blood Cells Sales Growth
4.6 Middle East & Africa Artificial Blood Cells Sales Growth
5 Americas
5.1 Americas Artificial Blood Cells Sales by Country
5.1.1 Americas Artificial Blood Cells Sales by Country (2018-2023)
5.1.2 Americas Artificial Blood Cells Revenue by Country (2018-2023)
5.2 Americas Artificial Blood Cells Sales by Type
5.3 Americas Artificial Blood Cells Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Blood Cells Sales by Region
6.1.1 APAC Artificial Blood Cells Sales by Region (2018-2023)
6.1.2 APAC Artificial Blood Cells Revenue by Region (2018-2023)
6.2 APAC Artificial Blood Cells Sales by Type
6.3 APAC Artificial Blood Cells Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Artificial Blood Cells by Country
7.1.1 Europe Artificial Blood Cells Sales by Country (2018-2023)
7.1.2 Europe Artificial Blood Cells Revenue by Country (2018-2023)
7.2 Europe Artificial Blood Cells Sales by Type
7.3 Europe Artificial Blood Cells Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Artificial Blood Cells by Country
8.1.1 Middle East & Africa Artificial Blood Cells Sales by Country (2018-2023)
8.1.2 Middle East & Africa Artificial Blood Cells Revenue by Country (2018-2023)
8.2 Middle East & Africa Artificial Blood Cells Sales by Type
8.3 Middle East & Africa Artificial Blood Cells Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artificial Blood Cells
10.3 Manufacturing Process Analysis of Artificial Blood Cells
10.4 Industry Chain Structure of Artificial Blood Cells
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artificial Blood Cells Distributors
11.3 Artificial Blood Cells Customer
12 World Forecast Review for Artificial Blood Cells by Geographic Region
12.1 Global Artificial Blood Cells Market Size Forecast by Region
12.1.1 Global Artificial Blood Cells Forecast by Region (2024-2029)
12.1.2 Global Artificial Blood Cells Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Artificial Blood Cells Forecast by Type
12.7 Global Artificial Blood Cells Forecast by Application
13 Key Players Analysis
13.1 Dextro-Sang Corporation
13.1.1 Dextro-Sang Corporation Company Information
13.1.2 Dextro-Sang Corporation Artificial Blood Cells Product Portfolios and Specifications
13.1.3 Dextro-Sang Corporation Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Dextro-Sang Corporation Main Business Overview
13.1.5 Dextro-Sang Corporation Latest Developments
13.2 BioPure Corporation
13.2.1 BioPure Corporation Company Information
13.2.2 BioPure Corporation Artificial Blood Cells Product Portfolios and Specifications
13.2.3 BioPure Corporation Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 BioPure Corporation Main Business Overview
13.2.5 BioPure Corporation Latest Developments
13.3 Sangart
13.3.1 Sangart Company Information
13.3.2 Sangart Artificial Blood Cells Product Portfolios and Specifications
13.3.3 Sangart Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sangart Main Business Overview
13.3.5 Sangart Latest Developments
13.4 Northfield Laboratories
13.4.1 Northfield Laboratories Company Information
13.4.2 Northfield Laboratories Artificial Blood Cells Product Portfolios and Specifications
13.4.3 Northfield Laboratories Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Northfield Laboratories Main Business Overview
13.4.5 Northfield Laboratories Latest Developments
13.5 Baxter International
13.5.1 Baxter International Company Information
13.5.2 Baxter International Artificial Blood Cells Product Portfolios and Specifications
13.5.3 Baxter International Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Baxter International Main Business Overview
13.5.5 Baxter International Latest Developments
13.6 Dentritech
13.6.1 Dentritech Company Information
13.6.2 Dentritech Artificial Blood Cells Product Portfolios and Specifications
13.6.3 Dentritech Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Dentritech Main Business Overview
13.6.5 Dentritech Latest Developments
13.7 FluorO2 Therapeutics
13.7.1 FluorO2 Therapeutics Company Information
13.7.2 FluorO2 Therapeutics Artificial Blood Cells Product Portfolios and Specifications
13.7.3 FluorO2 Therapeutics Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 FluorO2 Therapeutics Main Business Overview
13.7.5 FluorO2 Therapeutics Latest Developments
13.8 Nuvox Pharma
13.8.1 Nuvox Pharma Company Information
13.8.2 Nuvox Pharma Artificial Blood Cells Product Portfolios and Specifications
13.8.3 Nuvox Pharma Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Nuvox Pharma Main Business Overview
13.8.5 Nuvox Pharma Latest Developments
13.9 Alpha Therapeutic Corporation
13.9.1 Alpha Therapeutic Corporation Company Information
13.9.2 Alpha Therapeutic Corporation Artificial Blood Cells Product Portfolios and Specifications
13.9.3 Alpha Therapeutic Corporation Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Alpha Therapeutic Corporation Main Business Overview
13.9.5 Alpha Therapeutic Corporation Latest Developments
13.10 HemoBioTech
13.10.1 HemoBioTech Company Information
13.10.2 HemoBioTech Artificial Blood Cells Product Portfolios and Specifications
13.10.3 HemoBioTech Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 HemoBioTech Main Business Overview
13.10.5 HemoBioTech Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Artificial Blood Cells Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Artificial Blood Cells Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Animal Hemoglobin
Table 4. Major Players of Human Hemoglobin
Table 5. Major Players of Stem Cell
Table 6. Major Players of Others
Table 7. Global Artificial Blood Cells Sales by Type (2018-2023) & (K Units)
Table 8. Global Artificial Blood Cells Sales Market Share by Type (2018-2023)
Table 9. Global Artificial Blood Cells Revenue by Type (2018-2023) & ($ million)
Table 10. Global Artificial Blood Cells Revenue Market Share by Type (2018-2023)
Table 11. Global Artificial Blood Cells Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Artificial Blood Cells Sales by Application (2018-2023) & (K Units)
Table 13. Global Artificial Blood Cells Sales Market Share by Application (2018-2023)
Table 14. Global Artificial Blood Cells Revenue by Application (2018-2023)
Table 15. Global Artificial Blood Cells Revenue Market Share by Application (2018-2023)
Table 16. Global Artificial Blood Cells Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Artificial Blood Cells Sales by Company (2018-2023) & (K Units)
Table 18. Global Artificial Blood Cells Sales Market Share by Company (2018-2023)
Table 19. Global Artificial Blood Cells Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Artificial Blood Cells Revenue Market Share by Company (2018-2023)
Table 21. Global Artificial Blood Cells Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Artificial Blood Cells Producing Area Distribution and Sales Area
Table 23. Players Artificial Blood Cells Products Offered
Table 24. Artificial Blood Cells Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Artificial Blood Cells Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Artificial Blood Cells Sales Market Share Geographic Region (2018-2023)
Table 29. Global Artificial Blood Cells Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Artificial Blood Cells Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Artificial Blood Cells Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Artificial Blood Cells Sales Market Share by Country/Region (2018-2023)
Table 33. Global Artificial Blood Cells Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Artificial Blood Cells Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Artificial Blood Cells Sales by Country (2018-2023) & (K Units)
Table 36. Americas Artificial Blood Cells Sales Market Share by Country (2018-2023)
Table 37. Americas Artificial Blood Cells Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Artificial Blood Cells Revenue Market Share by Country (2018-2023)
Table 39. Americas Artificial Blood Cells Sales by Type (2018-2023) & (K Units)
Table 40. Americas Artificial Blood Cells Sales by Application (2018-2023) & (K Units)
Table 41. APAC Artificial Blood Cells Sales by Region (2018-2023) & (K Units)
Table 42. APAC Artificial Blood Cells Sales Market Share by Region (2018-2023)
Table 43. APAC Artificial Blood Cells Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Artificial Blood Cells Revenue Market Share by Region (2018-2023)
Table 45. APAC Artificial Blood Cells Sales by Type (2018-2023) & (K Units)
Table 46. APAC Artificial Blood Cells Sales by Application (2018-2023) & (K Units)
Table 47. Europe Artificial Blood Cells Sales by Country (2018-2023) & (K Units)
Table 48. Europe Artificial Blood Cells Sales Market Share by Country (2018-2023)
Table 49. Europe Artificial Blood Cells Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Artificial Blood Cells Revenue Market Share by Country (2018-2023)
Table 51. Europe Artificial Blood Cells Sales by Type (2018-2023) & (K Units)
Table 52. Europe Artificial Blood Cells Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Artificial Blood Cells Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Artificial Blood Cells Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Artificial Blood Cells Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Artificial Blood Cells Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Artificial Blood Cells Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Artificial Blood Cells Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Artificial Blood Cells
Table 60. Key Market Challenges & Risks of Artificial Blood Cells
Table 61. Key Industry Trends of Artificial Blood Cells
Table 62. Artificial Blood Cells Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Artificial Blood Cells Distributors List
Table 65. Artificial Blood Cells Customer List
Table 66. Global Artificial Blood Cells Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Artificial Blood Cells Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Artificial Blood Cells Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Artificial Blood Cells Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Artificial Blood Cells Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Artificial Blood Cells Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Artificial Blood Cells Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Artificial Blood Cells Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Artificial Blood Cells Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Artificial Blood Cells Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Artificial Blood Cells Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Artificial Blood Cells Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Artificial Blood Cells Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Artificial Blood Cells Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Dextro-Sang Corporation Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 81. Dextro-Sang Corporation Artificial Blood Cells Product Portfolios and Specifications
Table 82. Dextro-Sang Corporation Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Dextro-Sang Corporation Main Business
Table 84. Dextro-Sang Corporation Latest Developments
Table 85. BioPure Corporation Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 86. BioPure Corporation Artificial Blood Cells Product Portfolios and Specifications
Table 87. BioPure Corporation Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. BioPure Corporation Main Business
Table 89. BioPure Corporation Latest Developments
Table 90. Sangart Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 91. Sangart Artificial Blood Cells Product Portfolios and Specifications
Table 92. Sangart Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Sangart Main Business
Table 94. Sangart Latest Developments
Table 95. Northfield Laboratories Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 96. Northfield Laboratories Artificial Blood Cells Product Portfolios and Specifications
Table 97. Northfield Laboratories Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Northfield Laboratories Main Business
Table 99. Northfield Laboratories Latest Developments
Table 100. Baxter International Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 101. Baxter International Artificial Blood Cells Product Portfolios and Specifications
Table 102. Baxter International Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Baxter International Main Business
Table 104. Baxter International Latest Developments
Table 105. Dentritech Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 106. Dentritech Artificial Blood Cells Product Portfolios and Specifications
Table 107. Dentritech Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Dentritech Main Business
Table 109. Dentritech Latest Developments
Table 110. FluorO2 Therapeutics Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 111. FluorO2 Therapeutics Artificial Blood Cells Product Portfolios and Specifications
Table 112. FluorO2 Therapeutics Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. FluorO2 Therapeutics Main Business
Table 114. FluorO2 Therapeutics Latest Developments
Table 115. Nuvox Pharma Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 116. Nuvox Pharma Artificial Blood Cells Product Portfolios and Specifications
Table 117. Nuvox Pharma Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Nuvox Pharma Main Business
Table 119. Nuvox Pharma Latest Developments
Table 120. Alpha Therapeutic Corporation Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 121. Alpha Therapeutic Corporation Artificial Blood Cells Product Portfolios and Specifications
Table 122. Alpha Therapeutic Corporation Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Alpha Therapeutic Corporation Main Business
Table 124. Alpha Therapeutic Corporation Latest Developments
Table 125. HemoBioTech Basic Information, Artificial Blood Cells Manufacturing Base, Sales Area and Its Competitors
Table 126. HemoBioTech Artificial Blood Cells Product Portfolios and Specifications
Table 127. HemoBioTech Artificial Blood Cells Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. HemoBioTech Main Business
Table 129. HemoBioTech Latest Developments
List of Figures
Figure 1. Picture of Artificial Blood Cells
Figure 2. Artificial Blood Cells Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Artificial Blood Cells Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Artificial Blood Cells Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Artificial Blood Cells Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Animal Hemoglobin
Figure 10. Product Picture of Human Hemoglobin
Figure 11. Product Picture of Stem Cell
Figure 12. Product Picture of Others
Figure 13. Global Artificial Blood Cells Sales Market Share by Type in 2022
Figure 14. Global Artificial Blood Cells Revenue Market Share by Type (2018-2023)
Figure 15. Artificial Blood Cells Consumed in Cardiovascular Diseases
Figure 16. Global Artificial Blood Cells Market: Cardiovascular Diseases (2018-2023) & (K Units)
Figure 17. Artificial Blood Cells Consumed in Anemia
Figure 18. Global Artificial Blood Cells Market: Anemia (2018-2023) & (K Units)
Figure 19. Artificial Blood Cells Consumed in Organ Transplant
Figure 20. Global Artificial Blood Cells Market: Organ Transplant (2018-2023) & (K Units)
Figure 21. Artificial Blood Cells Consumed in Others
Figure 22. Global Artificial Blood Cells Market: Others (2018-2023) & (K Units)
Figure 23. Global Artificial Blood Cells Sales Market Share by Application (2022)
Figure 24. Global Artificial Blood Cells Revenue Market Share by Application in 2022
Figure 25. Artificial Blood Cells Sales Market by Company in 2022 (K Units)
Figure 26. Global Artificial Blood Cells Sales Market Share by Company in 2022
Figure 27. Artificial Blood Cells Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Artificial Blood Cells Revenue Market Share by Company in 2022
Figure 29. Global Artificial Blood Cells Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Artificial Blood Cells Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Artificial Blood Cells Sales 2018-2023 (K Units)
Figure 32. Americas Artificial Blood Cells Revenue 2018-2023 ($ Millions)
Figure 33. APAC Artificial Blood Cells Sales 2018-2023 (K Units)
Figure 34. APAC Artificial Blood Cells Revenue 2018-2023 ($ Millions)
Figure 35. Europe Artificial Blood Cells Sales 2018-2023 (K Units)
Figure 36. Europe Artificial Blood Cells Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Artificial Blood Cells Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Artificial Blood Cells Revenue 2018-2023 ($ Millions)
Figure 39. Americas Artificial Blood Cells Sales Market Share by Country in 2022
Figure 40. Americas Artificial Blood Cells Revenue Market Share by Country in 2022
Figure 41. Americas Artificial Blood Cells Sales Market Share by Type (2018-2023)
Figure 42. Americas Artificial Blood Cells Sales Market Share by Application (2018-2023)
Figure 43. United States Artificial Blood Cells Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Artificial Blood Cells Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Artificial Blood Cells Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Artificial Blood Cells Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Artificial Blood Cells Sales Market Share by Region in 2022
Figure 48. APAC Artificial Blood Cells Revenue Market Share by Regions in 2022
Figure 49. APAC Artificial Blood Cells Sales Market Share by Type (2018-2023)
Figure 50. APAC Artificial Blood Cells Sales Market Share by Application (2018-2023)
Figure 51. China Artificial Blood Cells Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Artificial Blood Cells Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Artificial Blood Cells Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Artificial Blood Cells Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Artificial Blood Cells Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Artificial Blood Cells Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Artificial Blood Cells Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Artificial Blood Cells Sales Market Share by Country in 2022
Figure 59. Europe Artificial Blood Cells Revenue Market Share by Country in 2022
Figure 60. Europe Artificial Blood Cells Sales Market Share by Type (2018-2023)
Figure 61. Europe Artificial Blood Cells Sales Market Share by Application (2018-2023)
Figure 62. Germany Artificial Blood Cells Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Artificial Blood Cells Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Artificial Blood Cells Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Artificial Blood Cells Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Artificial Blood Cells Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Artificial Blood Cells Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Artificial Blood Cells Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Artificial Blood Cells Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Artificial Blood Cells Sales Market Share by Application (2018-2023)
Figure 71. Egypt Artificial Blood Cells Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Artificial Blood Cells Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Artificial Blood Cells Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Artificial Blood Cells Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Artificial Blood Cells Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Artificial Blood Cells in 2022
Figure 77. Manufacturing Process Analysis of Artificial Blood Cells
Figure 78. Industry Chain Structure of Artificial Blood Cells
Figure 79. Channels of Distribution
Figure 80. Global Artificial Blood Cells Sales Market Forecast by Region (2024-2029)
Figure 81. Global Artificial Blood Cells Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Artificial Blood Cells Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Artificial Blood Cells Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Artificial Blood Cells Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Artificial Blood Cells Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 人工血管細胞のグローバル市場予測2023-2029(Global Artificial Blood Cells Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 医療用人工血管のグローバル市場予測2023-2029
  • 装着型人工腎臓のグローバル市場予測2023-2029
  • 高分子材料大口径人工血管のグローバル市場2023：EPTFE、ポリエチレンテレフタレート、ポリウレタン、その他
  • 世界の医療用人工血管市場2023年：企業・地域・タイプ・用途別分析

    • ◆H&Iグローバルリサーチのお客様（例）◆